These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12948851)

  • 1. Synergistic effects of chemotherapeutic drugs in lymphoma cells are associated with down-regulation of inhibitor of apoptosis proteins (IAPs), prostate-apoptosis-response-gene 4 (Par-4), death-associated protein (Daxx) and with enforced caspase activation.
    Chow KU; Nowak D; Boehrer S; Ruthardt M; Knau A; Hoelzer D; Mitrou PS; Weidmann E
    Biochem Pharmacol; 2003 Sep; 66(5):711-24. PubMed ID: 12948851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO).
    Ng CP; Bonavida B
    Mol Cancer Ther; 2002 Oct; 1(12):1051-8. PubMed ID: 12481428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In lymphatic cells par-4 sensitizes to apoptosis by down-regulating bcl-2 and promoting disruption of mitochondrial membrane potential and caspase activation.
    Boehrer S; Chow KU; Beske F; Kukoc-Zivojnov N; Puccetti E; Ruthardt M; Baum C; Rangnekar VM; Hoelzer D; Mitrou PS; Weidmann E
    Cancer Res; 2002 Mar; 62(6):1768-75. PubMed ID: 11912153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors.
    Brieger A; Boehrer S; Schaaf S; Nowak D; Ruthardt M; Kim SZ; Atadja P; Hoelzer D; Mitrou PS; Weidmann E; Chow KU
    Biochem Pharmacol; 2004 Jul; 68(1):85-93. PubMed ID: 15183120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway.
    Srinivasula SM; Datta P; Fan XJ; Fernandes-Alnemri T; Huang Z; Alnemri ES
    J Biol Chem; 2000 Nov; 275(46):36152-7. PubMed ID: 10950947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
    Ng CP; Zisman A; Bonavida B
    Prostate; 2002 Dec; 53(4):286-99. PubMed ID: 12430140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
    Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
    Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
    Wu SJ; Ng LT; Lin CC
    Eur J Pharmacol; 2005 Aug; 518(2-3):96-106. PubMed ID: 16054126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ.
    Arnt CR; Chiorean MV; Heldebrant MP; Gores GJ; Kaufmann SH
    J Biol Chem; 2002 Nov; 277(46):44236-43. PubMed ID: 12218061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daxx overexpression in T-lymphoblastic Jurkat cells enhances caspase-dependent death receptor- and drug-induced apoptosis in distinct ways.
    Boehrer S; Nowak D; Hochmuth S; Kim SZ; Trepohl B; Afkir A; Hoelzer D; Mitrou PS; Weidmann E; Chow KU
    Cell Signal; 2005 May; 17(5):581-95. PubMed ID: 15683733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reovirus-induced apoptosis requires mitochondrial release of Smac/DIABLO and involves reduction of cellular inhibitor of apoptosis protein levels.
    Kominsky DJ; Bickel RJ; Tyler KL
    J Virol; 2002 Nov; 76(22):11414-24. PubMed ID: 12388702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In malignant myeloid cells expression of Daxx downregulates expression of p53 and of the inhibitors of apoptosis proteins.
    Boehrer S; Nowak D; Schaaf S; Bergmann M; Brieger A; Hoelzer D; Mitrou PS; Weidmann E; Chow KU
    Hematol J; 2004; 5(6):513-8. PubMed ID: 15570294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation.
    Rosato RR; Dai Y; Almenara JA; Maggio SC; Grant S
    Leukemia; 2004 Nov; 18(11):1780-8. PubMed ID: 15385934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria.
    Zhang XD; Zhang XY; Gray CP; Nguyen T; Hersey P
    Cancer Res; 2001 Oct; 61(19):7339-48. PubMed ID: 11585775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
    Alas S; Ng CP; Bonavida B
    Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and apoptosis in small cell lung cancer cells.
    Pardo OE; Lesay A; Arcaro A; Lopes R; Ng BL; Warne PH; McNeish IA; Tetley TD; Lemoine NR; Mehmet H; Seckl MJ; Downward J
    Mol Cell Biol; 2003 Nov; 23(21):7600-10. PubMed ID: 14560006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.
    Yang L; Mashima T; Sato S; Mochizuki M; Sakamoto H; Yamori T; Oh-Hara T; Tsuruo T
    Cancer Res; 2003 Feb; 63(4):831-7. PubMed ID: 12591734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2.
    Adrain C; Creagh EM; Martin SJ
    EMBO J; 2001 Dec; 20(23):6627-36. PubMed ID: 11726499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In AML cell lines Ara-C combined with purine analogues is able to exert synergistic as well as antagonistic effects on proliferation, apoptosis and disruption of mitochondrial membrane potential.
    Chow KU; Boehrer S; Napieralski S; Nowak D; Knau A; Hoelzer D; Mitrou PS; Weidmann E
    Leuk Lymphoma; 2003 Jan; 44(1):165-73. PubMed ID: 12691159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine.
    Chow KU; Boehrer S; Geduldig K; Krapohl A; Hoelzer D; Mitrou PS; Weidmann E
    Haematologica; 2001 May; 86(5):485-93. PubMed ID: 11410411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.